NCT00531544

A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

A SU011248 Expanded Access Protocol for Metastatic RCC Patients Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 350 (actual)
• Sponsor: King Faisal Specialist Hospital & Research Center · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

A SU011248 expanded access protocol for systemic therapy of patients with metastatic Renal Cell Carcinoma who are ineligible for participation in other SU011248 protocols but may derive benefit from treatment with SU011248

Conditions

• Metastatic Renal Cell Carcinoma

Interventions

Type	Name	Description
DRUG	SU011248	SU011248 Expanded Access Protocol for Systemic Therapy

Timeline

• Start date: 2007-02-01
• Primary completion: 2012-06-01
• Completion: 2012-06-01
• First posted: 2007-09-19
• Last updated: 2016-01-05

Locations

1 site across 1 country: Saudi Arabia